C Landersdorfer, C Kirkpatrick, J Bulitta… - 2006 AAPS Annual …, 2011 - aapsj.org Population Pharmacokinetics of Piperacillin at Two Dose Levels: Influence of Nonlinear Pharmacokinetics on the Pharmacodynamic Profile C. Landersdorfer 1, C. Kirkpatrick 2, J. Bulitta 1, M. Kinzig-Schippers 1, U. Holzgrabe 3, G. Drusano 4, F. Sörgel 1 1 IBMP, Nürnberg ... View as HTML - All 2 versions
SE Kaufman, RW Donnell… - American Journal of Health-System …, 2011 - ASHP Summary EI β-lactam therapy is now considered a key aspect of antimicrobial stewardship, and published evidence indicates that iv infusion of piperacillin–tazobactam over extended periods (eg, four hours) instead of the traditionally recommended 30 minutes may offer several ...
F Robin, M Krebs, J Delmas… - Journal of …, 2011 - Br Soc Antimicrob Chemo Results Piperacillin/tazobactam was bacteriostatic against most of the tested strains (15/16). Using a high inoculum, the piperacillin/tazobactam combination was not bactericidal against the 13 IRT-producing strains and one of the CMT-producing strains (1/3). A loss of ... Related articles - All 5 versions
MJ Connor Jr, C Salem, SR Bauer… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Sepsis and multisystem organ failure are common diagnoses affecting nearly three-quarters of a million Americans annually. Infection is the leading cause of death in acute kidney injury, and the majority of critically ill patients who receive continuous dialysis also ... Cited by 1 - Related articles - All 3 versions
P Whitaker, X Meng, SN Lavergne… - The Journal of …, 2011 - Am Assoc Immnol A mechanistic understanding of the relationship between the chemistry of drug Ag formation and immune function is lacking. Thus, mass spectrometric methods were employed to detect and fully characterize circulating Ags derived from piperacillin in patients undergoing ... Related articles - All 3 versions